You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARGOS-SC

Showing 1 - 25 of 1,480
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open Angle Glaucoma Trial in Germany, Switzerland (ARGOS-SC suprachoroidal pressure sensor)

Active, not recruiting
  • Glaucoma
  • Open Angle Glaucoma
  • ARGOS-SC suprachoroidal pressure sensor
  • Bochum, Germany
  • +4 more
Mar 31, 2022

Glaucoma, Open Angle Glaucoma Trial in Germany, Switzerland (ARGOS-SC suprachoroidal pressure sensor)

Completed
  • Glaucoma
  • Open Angle Glaucoma
  • ARGOS-SC suprachoroidal pressure sensor
  • Bochum, Germany
  • +4 more
Nov 1, 2021

New Barrett TAL Formula With Argos Measurements: A Multicenter

Recruiting
  • Cataract
  • Argos
  • Encino, California
  • +5 more
Oct 10, 2023

Argos in Conjunction With Alcon Vision Suite Following

Recruiting
  • Cataract
  • Clareon PanOptix and AcrySof Vivity IOL implantation Alcon Vision Suite and Argos biometer
  • Abbotsford, British Columbia, Canada
    Valley Laser Eye Centre
Jun 2, 2023

Variability Across Automated Biometry Devices

Recruiting
  • Myopia
  • Orbscan II
  • +8 more
  • Houston, Texas
    Berkeley Eye Center
Sep 14, 2023

Comparative STudy of ARGos Biometer Compared to UltraSound

Not yet recruiting
  • Cataract
    • Bobigny, France
      Hôpital Avicenne
    Sep 6, 2022

    Two Swept Source Optical Coherence Tomography Biometers

    Completed
    • Cataract
    • Argos
    • IOLMaster 700
    • Frankfort, Illinois
      Multack Eye Care
    Feb 17, 2023

    Primary Open-angle Glaucoma Trial in Germany (ARGOS-IO Sensor Pressure System)

    Completed
    • Primary Open-angle Glaucoma
    • ARGOS-IO Sensor Pressure System
    • Aachen, Germany
    • +3 more
    Jul 11, 2022

    Three Swept-source Optical Coherence Biometry Devices in Long

    Recruiting
    • Cataract
    • Biometry
    • Vienna, Austria
      Hanusch Hospital, Department of Ophthalmology
    Oct 12, 2022

    Melanoma Trial in Worldwide (relatlimab+nivolumab, relatlimab+nivolumab+rHuPH20, nivolumab)

    Not yet recruiting
    • Melanoma
    • Anchorage, Alaska
    • +28 more
    Oct 20, 2023

    Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Drug and medical device
    • Poitiers, France
      CHU Poitiers
    Jun 1, 2023

    Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

    Not yet recruiting
    • Crohn's Disease
    • Risankizumab SC
    • Placebo for risankizumab
    • (no location specified)
    Sep 26, 2023

    Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

    Recruiting
    • Alzheimer Disease
    • Daejeon, Korea, Republic of
      Chungnam National University Hospital
    Nov 17, 2023

    Myositis Trial (EFG PH20 SC)

    Not yet recruiting
    • Myositis
    • EFG PH20 SC
    • (no location specified)
    Jul 28, 2023

    HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

    Not yet recruiting
    • HIV Infections
    • Las Vegas, Nevada
    • +1 more
    Aug 21, 2023

    Injectable Contraception Cohort Study in Punjab, Pakistan

    Not yet recruiting
    • Contraceptive Usage
    • Contraceptive usage
    • (no location specified)
    Mar 7, 2023

    Relapsed/Refractory Multiple Myeloma Trial (Isatuximab, Carfilzomib, Dexamethasone)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • (no location specified)
    Feb 3, 2023

    Healthy Volunteers Trial (ABP 501, Adalimumab)

    Completed
    • Healthy Volunteers
    • (no location specified)
    Aug 9, 2023

    Von Willebrand Diseases Trial in Vienna (VGA039, Placebo)

    Recruiting
    • Von Willebrand Diseases
    • Vienna, Austria
      Medical University of Vienna
    Mar 20, 2023

    Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)

    Recruiting
    • Advanced Solid Malignancies
    • West Hollywood, California
    • +13 more
    Jan 31, 2023

    ST Elevation Myocardial Infarction Trial in Isehara (Percutaneous coronary intervention)

    Enrolling by invitation
    • ST Elevation Myocardial Infarction
    • Percutaneous coronary intervention
    • Isehara, Kanagawa, Japan
      Tokai University Hospital
    Nov 21, 2022

    Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Tucson, Arizona
    • +191 more
    Aug 11, 2022

    Healthy Volunteers Trial in Anaheim, Overland Park (BIIB107, Placebo)

    Recruiting
    • Healthy Volunteers
    • Anaheim, California
    • +2 more
    Jan 9, 2023

    Healthy Volunteers Trial (ARGX-119, Placebo)

    Not yet recruiting
    • Healthy Volunteers
    • ARGX-119
    • Placebo
    • (no location specified)
    Jan 2, 2023

    Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

    Completed
    • Migraine
    • Major Depressive Disorder
    • Little Rock, Arkansas
    • +63 more
    Dec 7, 2022